RET and medullary thyroid gland carcinoma: In the present series, independently from age at surgery, asymptomatic H-risk RET mutation carriers had a significant greater risk to harbor an MTC compared to those patients carrying a MOD-risk RET mutation (93% vs. 62.5%).